141 related articles for article (PubMed ID: 7898770)
1. Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs.
Grassi C; Magnelli V; Carabelli V; Sher E; Carbone E
Neurosci Lett; 1994 Nov; 181(1-2):50-6. PubMed ID: 7898770
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells.
Magnelli V; Grassi C; Parlatore E; Sher E; Carbone E
FEBS Lett; 1996 May; 387(1):47-52. PubMed ID: 8654565
[TBL] [Abstract][Full Text] [Related]
3. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Johnston I; Lang B; Leys K; Newsom-Davis J
Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
[TBL] [Abstract][Full Text] [Related]
5. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
Peers C; Lang B; Newsom-Davis J; Wray DW
J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
[TBL] [Abstract][Full Text] [Related]
6. Voltage-dependent noradrenergic modulation of omega-conotoxin-sensitive Ca2+ channels in human neuroblastoma IMR32 cells.
Pollo A; Lovallo M; Sher E; Carbone E
Pflugers Arch; 1992 Oct; 422(1):75-83. PubMed ID: 1331978
[TBL] [Abstract][Full Text] [Related]
7. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
Engisch KL; Rich MM; Cook N; Nowycky MC
J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
Giovannini F; Sher E; Webster R; Boot J; Lang B
Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
[TBL] [Abstract][Full Text] [Related]
10. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.
Smith DO; Conklin MW; Jensen PJ; Atchison WD
J Physiol; 1995 Aug; 487(1):115-23. PubMed ID: 7473242
[TBL] [Abstract][Full Text] [Related]
11. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
Spillane J; Ermolyuk Y; Cano-Jaimez M; Lang B; Vincent A; Volynski KE; Kullmann DM
Neurology; 2015 Feb; 84(6):575-9. PubMed ID: 25589670
[TBL] [Abstract][Full Text] [Related]
12. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
Xu YF; Hewett SJ; Atchison WD
J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
Flink MT; Atchison WD
J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
[TBL] [Abstract][Full Text] [Related]
14. Ca currents in human neuroblastoma IMR32 cells: kinetics, permeability and pharmacology.
Carbone E; Sher E; Clementi F
Pflugers Arch; 1990 Apr; 416(1-2):170-9. PubMed ID: 1693767
[TBL] [Abstract][Full Text] [Related]
15. Binding of Lambert-Eaton myasthenic syndrome IgG to synaptosomal proteins does not correlate with an inhibition of calcium uptake.
Martin-Moutot N; Lang B; Newsom-Davis J; Seagar M
Neurosci Lett; 1995 Mar; 187(2):115-8. PubMed ID: 7783957
[TBL] [Abstract][Full Text] [Related]
16. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Waterman SA; Lang B; Newsom-Davis J
Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
[TBL] [Abstract][Full Text] [Related]
17. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons.
GarcĂa KD; Mynlieff M; Sanders DB; Beam KG; Walrond JP
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9264-9. PubMed ID: 8799189
[TBL] [Abstract][Full Text] [Related]
19. Action of Ca2+ agonists/antagonists in mammalian peripheral neurons.
Carbone E; Clementi F; Formenti A; Pollo A; Sher E
Cell Biol Int Rep; 1989 Dec; 13(12):1155-64. PubMed ID: 2561466
[TBL] [Abstract][Full Text] [Related]
20. Separation of calcium currents in retinal ganglion cells from postnatal rat.
Guenther E; Rothe T; Taschenberger H; Grantyn R
Brain Res; 1994 Jan; 633(1-2):223-35. PubMed ID: 7907933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]